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Hidden auditory neuropathy is characterized by reduced performances in challenging
auditory tasks with the preservation of hearing thresholds, resulting from diffuse loss of
cochlear inner hair cell (IHC) synapses following primary degeneration of unmyelinated
terminals of auditory fibers. We report the audiological and electrophysiological findings
collected from 10 members (4 males, 6 females) of a large Italian family affected by
dominant optic atrophy, associated with the OPA8 locus, who complained of difficulties
in understanding speech in the presence of noise. The patients were pooled into two
groups, one consisting of 4 young adults (19–50 years) with normal hearing thresholds,
and the other made up of 6 patients of an older age (55–72 years) showing mild hearing
loss. Speech perception scores were normal in the first group and decreased in the
second. Otoacoustic emissions (OAEs) and cochlear microphonics (CMs) recordings
were consistent with preservation of outer hair cell (OHC) function in all patients, whereas
auditory brainstem responses (ABRs) showed attenuated amplitudes in the first group
and severe abnormalities in the second. Middle ear acoustic reflexes had delayed peak
latencies in all patients in comparison with normally hearing individuals. Transtympanic
electrocochleography (ECochG) recordings in response to 0.1 ms clicks at intensities
from 120 to 60 dB peak equivalent SPL showed a reduction in amplitude of both
summating potential (SP) and compound action potential (CAP) together with delayed
CAP peak latencies and prolonged CAP duration in all patients in comparison with a
control group of 20 normally hearing individuals. These findings indicate that underlying
the hearing impairment in OPA8 patients is hidden AN resulting from diffuse loss of
IHCs synapses. At an early stage the functional alterations only consist of abnormalities
of ABR and ECochG potentials with increased latencies of acoustic reflexes, whereas
reduction in speech perception scores become apparent with progression of the
disease. Central mechanisms increasing the cortical gain are likely to compensate for
the reduction of cochlear input.
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INTRODUCTION
Dominant optic atrophy (DOA) is amongst the most common
inherited optic neuropathies, with a prevalence of about 1 in
25,000–30,000 (Lenaers et al., 2012; Yu-Wai-Man and Chinnery,
2013), and is characterized by a slowly progressive bilateral
visual loss beginning in childhood (Kjer, 1959). Typically, there
is selective neurodegeneration of retinal ganglion cells (RGCs)
mostly affecting the small fibers of the papillo-macular bundle
that leads to temporal pallor at fundus examination, central
scotoma and loss of visual acuity (Carelli et al., 2004; Yu-Wai-
Man et al., 2011). Up to 75% of DOA cases are due to dominant
heterozygous mutations affecting the OPA1 gene (Alexander
et al., 2000; Delettre et al., 2000; Lenaers et al., 2012). Missense
mutations in the GTPase domain result in a multisystemic
disease involving central and peripheral nervous systems, skeletal
muscle and stability of mitochondrial DNA (Amati-Bonneau
et al., 2008; Hudson et al., 2008; Yu-Wai-Man et al., 2010).
Besides optic atrophy, sensorineural hearing loss is the earliest
and most frequent clinical feature associated with OPA1 missense
mutations (Yu-Wai-Man et al., 2010; Leruez et al., 2013).
The genetic basis of DOA not linked to OPA1 mutations is
increasingly being elucidated, and a growing list of other genes
involved in the recurrent association of syndromic DOA and
sensorineural deafness is being reported. This includes OPA3
with the peculiar association with cataracts (Reynier et al., 2004;
Sergouniotis et al., 2015), Wolframin 1 (Eiberg et al., 2006;
Rendtorff et al., 2011), MFN2 (Rouzier et al., 2012), SPG7 (Klebe
et al., 2012), and DNM1L (Gerber et al., 2017). Almost all
these genes encode proteins involved in mitochondrial functions,
affecting mitochondrial dynamics and oxidative phosphorylation
(Yu-Wai-Man et al., 2016).
In previous studies we characterized sensorineural deafness in
patients harboring missense mutations in the OPA1 gene (Huang
et al., 2009; Santarelli et al., 2015). Our findings indicate that
underlying the hearing impairment is a disordered synchrony of
auditory nerve fiber activity resulting from neural degeneration
of their distal portion (Santarelli et al., 2015). Indeed, OPA1
patients displayed the clinical profile of auditory neuropathy
(AN) consisting of moderate hearing loss with disproportionate
impairment of speech perception, abnormal brainstem responses
and presence of normal otoacoustic emissions (OAE) (Starr
et al., 1996). Transtympanic electrocochleography (ECochG)
showed normal receptor potentials, cochlear microphonic (CM)
and summating potential (SP), consistent with preservation of
hair cell activity, whereas the synchronous compound action
potential (CAP) recorded in normally hearing individuals was
replaced by a prolonged negative low-amplitude response, which
is believed to originate from the activity of degenerated neural
terminals based on the effects of adaptation induced by high
stimulation rates.
The term “hidden auditory neuropathy” was coined recently
(Schaette and McAlpine, 2011) to indicate the auditory
dysfunction resulting from diffuse loss of inner hair cell (IHCs)
synapses in the cochlea with preservation of hearing thresholds.
The decrease in number of synaptic contacts is consequent to
primary degeneration of unmyelinated neural terminals (see
Liberman and Kujawa, 2017 for a review). Studies performed in
animal models revealed that behavioral hearing thresholds are
relatively unaffected until IHC loss exceeds 40–60% (Liberman
and Kujawa, 2017; Salvi et al., 2017). In both humans and in
animal models, the reduction of the cochlear output results
in a decrease in amplitude of ABR Wave I and in reduced
performance in challenging auditory tasks relying on temporal
cues such as speech understanding in noisy environments.
Hidden AN is believed to result from acoustic trauma (Liberman
and Kujawa, 2017), aging (Parthasarathy and Kujawa, 2018),
and ototoxic drug administration (Liberman and Kujawa, 2017;
Salvi et al., 2017).
In a previous paper we described a new form of DOA
in a large family of Italian descent whose affected subjects
complained of difficulties in understanding speech and showed
an increased central conduction time at somato-sensory evoked
potentials recording, together with cardiac abnormalities (OPA8)
(Carelli et al., 2011). Genome-wide linkage revealed a locus
on chromosome 16 in the critical interval 16q21–q22. In this
study we present the specific features of the hearing dysfunction
affecting this family. The findings collected from audiological
studies, speech perception evaluation and transtympanic
electrocochleography are consistent with hidden AN.
MATERIALS AND METHODS
Subjects
We evaluated hearing function in 10 subjects (4 males; mean age
52.6 years; age range 19–71) from the original family mapping at
the OPA8 locus. Clinical details from all patients are summarized
in Table 1, whereas audiological results are reported in Table 2.
In all subjects the onset of vision problems occurred in
childhood or the late teens. The auditory symptoms appeared
years later as subtle difficulties in understanding speech in noisy
environments, except for subject #4, who presented auditory
problems as the first symptom. At the time of evaluation, all
subjects complained of difficulty in understanding speech in the
presence of background noise; four patients also complained of
impaired speech perception in quiet environments. Four patients
reported tinnitus, whereas one complained of vertigo.
Subjects underwent audiological assessment including pure
tone and speech audiometry, speech perception measures and
OAEs and ABRs recordings, all performed during the same
session. They were submitted to ECochG recording except for
subjects #8 and #9.
This study was carried out in accordance with the
recommendations of the local institutional ethical committee.
All subjects gave written informed consent in accordance with
the Declaration of Helsinki.
Audiological Studies
Audiometry
We tested hearing thresholds at frequencies from 250 to 8000 Hz
(Grason-Stadler GSI 61 audiometer) in a sound-attenuating
room. The degree of hearing impairment was defined by the
pure tone average (PTA) threshold levels at 0.5, 1, 2, and 4 kHz,
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TABLE 1 | Clinical and neurological findings from OPA8 patients.
Case Skeletal muscle biopsy mtDNA
deletion
Other Clinical features
#1 Normal None Optic atrophy, prolapse
mitral valve, ↑central
conduction at SSEPs
#2 n.a. – Optic atrophy
#3 n.a. – Optic atrophy
#4 n.a. – Optic atrophy
#5 Slight myopathic changes
with diffuse increase of
subsarcolemmal SDH







#4 n.a. – Optic atrophy
#7 n.a. – Optic atrophy
#9 n.a. – Optic atrophy
#2 Normal None Optic atrophy, mitral
insufficiency, ↑central
conduction at SSEPs








n.a., not available; COX, cytochrome c oxidase; SDH, succinate dehydrogenase;
SSEPs, somatosensory evoked potentialsxf.
and was classified as mild (PTA 21–40 dB HL), moderate (PTA
41–70 dB HL), severe (PTA 71–95 dB HL), and profound
(PTA > 95 dB HL) (study group on terminology, definition and
hearing assessment, 1996) (Mazzoli et al., 2003).
Speech Audiometry
Articulation gain curves were obtained using disyllabic,
phonetically balanced words from an Italian wordlist for adults
(Bocca and Pellegrini, 1950). Ten words were presented for
each stimulus intensity. At each level, scoring was based on the
percentage of words correctly repeated by the subject.
Speech Perception Tests
Speech perception tests were performed in a sound-attenuated
room. Speech stimuli were presented in the free field through
one loudspeaker placed one meter away from the front of the
subject’s head. Competing background noise was presented from
two additional loudspeakers placed laterally at an angle of 90◦
on each side of the subject’s head at one meter. Competing
noise used was continuous speech noise (Interacoustics AD 229E)
calibrated in the free field by means of a Brüel and Kjaer 4165
microphone (mounted on the 800 B Larson-Davis sound level
meter) placed in a position corresponding to the subject’s head.
Speech material comprised digital anechoic recordings of a native
Italian female speaker. The speech stimulus intensity was kept at
70 dB (A). Both stimuli and noise files were stored on computer
for transfer directly to the loudspeakers. Speech and noise files
were normalized for output intensity levels at the signal-to-noise
ratio (S/N) of 0 dB.
Tests were administered at 70 dB(A) in quiet, and in the
presence of competing noise presented at three signal-to-noise
(S/N) ratios (+10, +5, 0). In the word recognition test, subjects
were presented with one of four randomly chosen lists of
disyllabic words, each list consisting of 25 items. The speech
material was obtained from the protocol of patient candidacy
for cochlear implantation for the Italian language (Quaranta
et al., 1996). Subjects were requested to respond by repeating the
words they heard.
Consonant identification was evaluated by presenting
consonant confusion matrices compiled from two presentations,
each comprising the 16 consonants, b d f g k l m n p r s t v z j t
∫
presented in an “a-consonant-a” context (chance 6%). Subjects
were asked to respond by repeating the speech signal perceived.
Gap Detection
We used the procedures reported in Zeng et al. (2005). Briefly,
tests were performed in free field at an intensity of 30 dB above
threshold (with respect to the PTA value calculated for the better
ear). Gap detection was evaluated by inserting a silent interval
in the center of broadband white noise (20–14,000 Hz). The
stimulus paradigm consisted of a three-interval, three-alternative,
forced-choice, two-down and one-up procedure to fulfill the
70.7% correct response criterion. White noise was calibrated in
the free field by means of a Brüel and Kjaer 4165 microphone
(mounted on the 800 B Larson-Davis sound level meter).
Data collected from patients were compared to the corres-
ponding values obtained from 16 normally hearing subjects (age
range 18–51 years).
Middle Ear Muscle Reflex Testing
Acoustic reflex thresholds were measured ipsilaterally and
contralaterally to the stimulated ear (Grason-Stadler GSI
TympStar impedance audiometer). They were considered absent
when no response was found at intensities higher than 110 dB HL.
Peak latencies were measured on the averaged waveforms
obtained in response to tone stimuli of 300 ms duration and
18 ms rise/fall- time which were presented at an intensity of 10 dB
above threshold at frequencies of 0.5, 1, 2, and 4 kHz. Five stimuli
were averaged for each waveform. Peak latency was measured at
the maximum negative deflection from baseline relative to the
response onset defined at the time when the immittance signal
deviated from the pre-stimulus baseline (Gelfand, 2002).
Data collected from patients were compared to the
corresponding values obtained from 16 normally hearing
subjects (age range 18–51 years).
Distortion Product Otoacoustic Emissions (DPOAEs)
Distortion product otoacoustic emissions (DPOAEs) were
obtained using the ILO-92 OAE system. Primary tones were
presented at 70 dB SPL and the f2/f1 ratio was kept at 1.21. The
frequency was increased in 1/4 octave steps from 708 to 6299 Hz.
Four spectral averages were summed for each stimulus condition.
Electrophysiological Studies
Auditory Brainstem Responses (ABRs)
Potentials were recorded from scalp electrodes (vertex to mastoid
ipsilateral to the stimulated ear) in response to 2,000 trials
of alternating polarity clicks presented monaurally (TDH-50
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TABLE 2 | Audiological Data from OPA8 subjects.
Subjects# #1 #2 #3 #4 #5 #6 #7 #8 #9 #10
Clinical
Gender F F M F F M M F F M
Age tested 48 27 19 50 72 55 65 68 69 64
Age onset 22 9 10 20 26 9 11 18 18 17
Sign at onset Vision Vision Vision Hearing Vision Vision Vision Vision Vision Vision
Deafness Noise Noise Noise Noise Quiet Quiet Quiet Quiet Noise Noise
Deaf onset − 24 − 8 64 40 − − − 54
Tinnitus − − − − Yes − Yes − Yes Yes
Vertigo − − − − − − − − Yes −
Audiology R/L
Hearing N/N N/N N/N N/N Mild/Mild Mild/Mild Mild/Mild Mild/Mild Mild/N Mild/Mild
PTA (dB) 10/10 10/11 11/15 11/11 29/34 20/25 33/31 31/34 30/10 21/21
LF (dB) 10/10 10/11 13/16 10/11 26/25 16/15 23/23 24/26 23/10 18/15
HF (dB) 10/15 20/13 10/10 13/22 43/60 32/58 55/53 53/52 53/17 38/42
Stapedial Reflexes∗ +/+ +/+ +/+ +/+ +/+ +/+ ABS/ABS +/+ +/+ +/+
OAEs +/+ +/+ +/+ +/+ ABS/ABS +/+ +/ABS +/+ +/+ +/+
Gap Det (ms) 5.4 3.8 0.7 6.0 5.0 3.4 11.0 5.6 7.0 6.0
ABRs R/L
Wave I (ms) 1.55/1.52 1.57/1.67 1.49/1.53 1.49/1.50 ABS/ABS 1.65/2.02 ABS/ABS ABS/ABS ABS/ABS ABS/ABS
Wave III (ms) 4.13/4.47 4.01/4.04 4.17/4.01 3.58/3.54 4.67/4.37 4.23/4.34 ABS/ABS ABS/ABS ABS/ABS ABS/ABS
Wave V (ms) 6.18/6.63 5.81/5.30 5.54/5.33 5.53/5.45 6.27/6.08 5.47/6.26 7.08/ABS ABS/7.03 ABS/ABS ABS/ABS
IP I–III (ms) 2.58/2.95 2.44/2.37 2.68/2.48 2.09/2.04 −/− 2.58/2.32 −/− −/− −/−
IP III–V (ms) 2.05/2.16 1.80/1.26 1.37/1.32 1.95/1.91 1.60/1.71 1.24/1.92 −/− −/− −/−
R/L, right ear/left ear; N, normal; PTA, pure tone average (average thresholds at 0.5, 1, 2, and 4 kHz); LF, low frequencies (average thresholds at 0.5, 1, and 2 kHz); HF,
high frequencies (average thresholds at 4, 6, and 8 kHz); ABS, absent; OAEs, otoacoustic emissions; Gap Det., Gap Detection; ABRs, auditory brainstem responses; IP,
inter-peak interval. Data are reported in bold when falling beyond the upper limit of the normal range measured for healthy controls in our laboratory. ∗Measured ipsilaterally
to the stimulated ear.
transducer earphone) at a maximum intensity of 125 dB peak
equivalent (p.e.) SPL (corresponding to 90 dB nHL, referred to
the psychoacoustical threshold of normally hearing subjects). The
filter settings of the amplifier were set between 5 and 4,000 Hz.
Electrocochleography (ECochG)
Electrocochleography recording was carried out in 8 out
of 10 patients who had signed an informed consent form.
ECochG protocol was assessed by the regional body for quality
control of clinical and therapeutic procedures (CCHSA, Veneto
Region 2007–2010).
Under local anesthesia (lidocaine) a sterile stainless steel
needle electrode (0.7 mm), insulated except for the tip, was passed
through the tympanic membrane and placed on the promontory
wall with the aid of an operating microscope. Stimuli consisted of
0.1 ms rarefaction and condensation clicks, delivered separately
in the free field by means of two high frequency drivers (Electro-
Voice DH1A/2MT 16) mounted on a single polyurethane horn
(Electro-Voice HP420) at a maximum intensity of 120 dB peak
equivalent (p.e.) SPL (corresponding to 90 dB nHL relative to
the psychoacoustic threshold of normally hearing subjects). The
stimulus was calibrated in the free field by means of a Brüel
and Kjaer 4165 microphone (mounted on an 800 B Larson-
Davis sound level meter) placed at 1 m from the base of
the polyurethane horn, which corresponded to the distance of
the patient’s ear from the horn. The procedure of comparing
the peak-to-peak amplitude of the click to the peak-to-peak
amplitude of a 2 kHz tone was utilized to calibrate the click level
(p.e. SPL) (Santarelli et al., 2008).
Condensation and rarefaction clicks were delivered separately
for seven intensity levels from 120 to 60 p.e. SPL. The stimulus
paradigm consisted of an initial click, followed 15 ms later by
ten clicks with an inter-stimulus interval of 2.9 ms, and the
sequence was repeated every 191 ms (Santarelli et al., 2008;
Santarelli and Arslan, 2013).
The potentials were differentially amplified (50,000 times),
filtered (5–8,000 Hz) and digitized (25 µs) for averaging
(500 trials). The procedure of averaging the responses evoked
separately by condensation and rarefaction clicks was applied
to cancel the CM and extract the CAP with the superimposed
SP. The resulting curve was subtracted from the potential
evoked by condensation clicks to obtain the CM (Eggermont,
1976; Santarelli et al., 2008). Since CM attenuation was often
incomplete at high stimulus intensity and CM spectral energy was
at maximum between 1,500 and 3,000 Hz, a low pass digital filter
(12 dB/octave, cutoff frequency 2,000 Hz) was used to attenuate
the residual CM, where needed (Santarelli et al., 2008).
After canceling the CM, the ECochG waveform begins with
the receptor SP, which appears as an initial negative deflection
arising from baseline and preceding the neural CAP (Eggermont,
1976; Santarelli and Arslan, 2013, 2015). Latency was defined
relative to CM onset in milliseconds (ms). Amplitude was
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computed relative to the period 1 ms before CM onset in
microvolt (µV). We defined latency and amplitude of SP at the
initial negative deflection arising from baseline while CAP peak
amplitude was measured at maximum negative potential (with
respect to baseline).
Cochlear potentials recorded from patients were compared
to the ECochG data previously collected from 20 children (age
range 3.5–6.5 years) tested for presumed cochlear deafness,
but who proved to have normal cochlear function (Santarelli
et al., 2008; Santarelli and Arslan, 2013, 2015). Although the
controls were considerably younger than OPA8 subjects, the age
difference cannot be considered a major limitation, since both
amplitude and latency of the CAP peak recorded in children
of the control group in response to click stimulation at several
intensities were comparable to the corresponding values reported
in other studies for normally hearing adults (Eggermont, 1976;
Noguchi et al., 1999; Schoonhoven, 2007). This is in line with our
knowledge of the timing of developmental maturation processes
in the cochlea and auditory nerve. Indeed, the latency of ABR
wave I, which reflects the synchronous activation of auditory
nerve fibers, is comparable to adult values by 1–2 years of life
(Eggermont et al., 1991).
Statistical Analysis
Analysis of variance (ANOVA) for repeated measures was carried
out to analyze ECochG and acoustic reflex measures. Separate
two-factor ANOVAs with factors of group and stimulus intensity
were used to evaluate latency, amplitude and duration measures
of ECochG potentials. Factors of group and tone frequency
(0.5, 1, 2, and 4 kHz) were used to evaluate acoustic reflex
thresholds and peak latencies.
The level of significance was P < 0.05.
Values contained in figures indicate mean± standard error.
RESULTS
Hearing Thresholds
Hearing thresholds were within normal limits in 4 subjects and
appeared only mildly elevated in five (Table 2). One subject (#9)
had normal hearing thresholds in one ear and mild hearing loss
in the other ear. In the hearing-impaired patients hearing loss
mostly involved the high frequencies.
Subjects were pooled into two groups based on their PTA
values. The first group comprised patients with normal hearing
thresholds bilaterally (PTA 0–15 dB; n = 4), whereas subjects with
mild hearing loss in one ear at least (PTA 20-34 dB; n = 6) formed
the second group.
Speech Audiometry
Articulation-gain curves were obtained bilaterally from all
subjects. Figure 1 shows the mean hearing thresholds (left side)
and the mean articulation-gain curves (right side) obtained
from each group of OPA8 patients, compared to the mean
functions obtained at corresponding PTA values from two large
samples of subjects of comparable age who have undergone
audiometric evaluation over the last 10 years at our Department.
The two control groups included normally hearing individuals
(384 ears, age range 18–47 years) and patients with cochlear
hearing loss (575 ears, range 55–69 years), respectively. Subject
#9 was included in both classes as she had asymmetrical
hearing thresholds.
The mean articulation gain function calculated for the OPA8
ears with normal hearing thresholds (Figure 1A) closely followed
the corresponding curve obtained from healthy controls. In
contrast, the group of OPA8 patients with mild hearing loss
(Figure 1B) showed lower scores compared to the hearing-
impaired controls. These findings indicate that the decrease in
speech intelligibility in the group of the hearing impaired OPA8
patients cannot be attributed solely to the increase of hearing
threshold, as is the case for subjects with cochlear hearing loss.
Speech Perception
Figure 2 shows individual scores on the recognition of disyllables
and identification of consonants obtained from each group of
OPA8 patients in a quiet environment and in the presence
of background noise, compared with the corresponding mean
values measured for two control age-matched groups, one of 14
normally hearing individuals (age range 18–49 years), and the
other comprising 10 patients with mild cochlear hearing loss
(range 51–69 years). Patient #9 was included in the group of
patients with PTA 10–15 dB according to the hearing threshold
of the better ear as speech stimuli were presented in the free field.
Speech perception scores measured for OPA8 patients with
normal hearing thresholds (Figure 2A) were within the range
calculated for healthy controls in three subjects. Of the remaining
two patients, subject #4 showed reduced scores on the consonant
recognition test in the presence of high level of noise and subject
#9 performed worse than controls at all levels of noise particularly
on the consonant recognition test. In the OPA8 group with mild
hearing loss (Figure 2B), three subjects (subjects #5, #7, #10)
performed worse than controls on both tests and particularly on
the consonant identification test in the presence of noise, possibly
due to the involvement in a more difficult perceptual task. Two
subjects performed worse than controls also in quiet (subjects #5,
#7). In this group scores were remarkably lower in comparison
with OPA8 patients with normal hearing thresholds.
Gap Detection
Individual values collected on gap detection test are reported in
Table 2. In all but one subject (#7), gap detection values were
comparable to the scores collected from the group of normally
hearing controls (normal gap detection range 2.3–7.5 ms).
Middle Ear Muscle Acoustic Reflexes
Middle ear muscle reflexes were detected in all but one
patient (#5) (Table 2).
In Figure 3A the acoustic reflexes obtained in one represen-
tative OPA8 subject (#2) at stimulus frequencies of 500, 1,000,
2,000, and 4,000 Hz at suprathreshold intensity (10 dB above
threshold) are compared with the corresponding waveforms
recorded from one normally hearing control. In the OPA8
patient, the initial negative deflection slowed down, so that the
peak latency was delayed compared to the control.
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FIGURE 1 | Articulation gain curves from patients with OPA8-related DOA are reported for two groups of subjects, one showing normal thresholds (A) and the other
with mild hearing loss (B). On the left, means and standard errors of hearing thresholds are superimposed on the corresponding values collected from two control
age-matched groups with corresponding PTA values. On the right, the mean articulation functions (blue lines) with 95% confidence limits (shadowed areas) obtained
from each group of OPA8 patients have been superimposed on the corresponding mean articulation functions (dashed lines) calculated for controls. Speech
intelligibility was within normal limits in the group of OPA8 patients with normal hearing thresholds, whereas a decrease of reception scores compared to controls
was observed in the OPA8 group with mild hearing loss.
Individual thresholds and peak latencies are compared for
OPA8 patients and one control group of normally hearing
individuals in Figure 3B. No significant differences were found in
reflex thresholds (ANOVA; F = 0.09, P = 0.761544), whereas peak
latencies were significantly delayed in OPA8 subjects compared
to controls (ANOVA; F = 45.33, P < 0.001).
Distortion Product Otoacoustic
Emissions (DPOAEs)
Distortion product otoacoustic emissions were recorded from
all but one patient (#5) (Table 2). The responses were
detected bilaterally, except for subject #7, who showed OAEs
only in one ear.
Auditory Brainstem Responses (ABRs)
In Figure 4 the individual ABR recordings obtained from all
OPA8 subjects are compared to the ABR waveforms collected
from one healthy control and from two adult patients carrying
a missense mutation in the OPA1 gene. Peak latency values of
individual ABR waves are reported in Table 2.
Overall, ABR amplitudes were attenuated in all OPA8 subjects
in comparison with the normally hearing control except for
subject #4, who showed normal ABRs. Nevertheless, brainstem
potentials showed remarkable differences between OPA8 subjects
with normal hearing thresholds and those with mild hearing
loss. Compared with the healthy control, the ABR waveforms
from the OPA8 group with normal thresholds (PTA 10–15 dB)
were markedly attenuated, but the response morphology was
preserved. Indeed, Wave I was detected in all ears with normal
latency; Waves III and V were identified in all subjects, although
with prolonged latency in some ears (bold characters in Table 2).
Moreover, in two subjects (#1, #3) the inter-peaks I–III latency
in one ear was beyond the upper limit of the normal range
measured for healthy controls in our laboratory (2.60 ms) (bold
characters in Table 2).
Auditory brainstem response alterations were much more
pronounced in the OPA8 group with mild hearing loss (PTA
20–34 dB). Indeed, ABR recordings showed no response in two
patients, a remarkably delayed Wave V in two other subjects,
while in the remaining two patients Waves III and V were
recorded with prolonged latency. Wave I was detected only in one
subject in this group (#6). Overall, ABR recordings resembled the
brainstem potentials obtained in OPA1 patients, who displayed
severe ABR abnormalities despite the relative preservation of
hearing thresholds (Santarelli et al., 2015).
Since reduction of suprathreshold Wave I amplitude has been
proposed as a measure of cochlear input decrease in auditory
synaptopathy for both mice and humans (Liberman and Kujawa,
2017), we compared the individual Wave I amplitudes measured
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FIGURE 2 | Speech perception scores from patients with OPA8-related DOA. Individual scores collected on open-set disyllable recognition and consonant
identification tests performed in quiet and in the presence of competing speech noise at three S/N ratios (+10, +5, 0) are shown for OPA8 subjects with normal
hearing thresholds (A) or mild hearing loss (B), superimposed on the mean values with 95% confidence limits (shadowed areas) calculated for two control
age-matched groups at corresponding PTA values.
at 90 dB nHL for OPA8 patients with normal hearing thresholds
with the corresponding values collected from a group of 14
normally hearing subjects (age range 20–57 years) (Figure 5).
Wave I amplitude was significantly reduced in the OPA8 group
compared to the healthy controls (t-test; t = 3.09612, P < 0.01).
Electrocochleography (ECochG)
Electrocochleography waveforms obtained after CM cancelation
showed remarkable differences in comparison with normally
hearing individuals and subjects with cochlear hearing loss. In
Figure 6 the ECochG waveforms recorded at stimulus intensities
from 120 to 60 dB p.e. SPL in four representative OPA8 patients –
two with normal hearing thresholds (A) and two with mild
hearing loss (B) – are superimposed, respectively, on the ECochG
potentials recorded from two control subjects: a normally
hearing individual and a subject with cochlear deafness with
comparable hearing thresholds. In addition, recordings collected
in two patients with auditory neuropathy due to mutations
in the OPA1 gene are displayed in the right panel. In the
healthy control (Figure 6A), the response begins with the
receptor summating potential (SP), which is believed to derive
from IHCs activation (Durrant et al., 1998). This is followed
by the CAP, originating from the synchronous activation of
auditory nerve fibers innervating the basal portion of the cochlea
(Eggermont, 1976). Decreasing the stimulus level results in a
gradual latency increase and amplitude reduction of both SP
and CAP peaks. The duration of the SP-CAP complex, as
measured from initial negative deflection to return to baseline,
is relatively constant at suprathreshold intensities but broadens
at low stimulus level. The ECochG waveforms obtained from
the subject with cochlear deafness (Figure 6B) show comparable
peak latencies and duration with respect to the normally
hearing control; however, the amplitude of both SP and CAP is
remarkably smaller.
The ECochG waveforms recorded from OPA8 patients began
with the SP potential, whose amplitude appeared markedly
reduced compared to the controls for OPA8 subjects with normal
hearing thresholds (Figure 6A) as well as for those showing
mild hearing loss (Figure 6B). SP potential was followed by
synchronous CAP, which displayed a smaller amplitude and a
delayed peak latency compared to controls for both OPA8 groups.
The attenuation in amplitude of ECochG potentials and the
delay of SP and CAP peak latency were less pronounced in
the group of OPA8 patients with normal hearing thresholds.
Indeed, subject #4 had normal ECochG responses (not shown),
while the ECochG waveforms recorded from the right ear in
subject #2 (Figure 6A) showed reduced CAP amplitude and
increased peak latency compared to the control; however, both
SP amplitude and latency were within the control range. These
findings support the hypothesis that in the youngest members
of the OPA8 family, synaptic damage was far less advanced
compared to elderly patients.
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FIGURE 3 | Acoustic middle ear reflexes from OPA8 patients and normally hearing controls. On the left (A) recordings obtained at stimulus frequencies of 500, 1,000,
2,000, and 4,000 Hz at suprathreshold intensity (10 dB above threshold) are shown for one normally hearing individual and one representative OPA8 patient (#2). On
the right (B), individual values of reflex threshold and peak latency are graphed for both OPA8 patients and normally hearing controls at stimulus frequencies from
500 to 4,000 Hz. Peak latencies appear remarkably prolonged in OPA8 patients compared to controls. Small vertical bars refer to onset and peak response latency.
The pattern of ECochG responses showed profound
differences in comparison to patients harboring missense
mutations in the OPA1 gene, as in the latter the synchronous
CAP was replaced by a prolonged low-amplitude negative
potential following an SP with a normal amplitude (Figure 6C).
Mean and individual values of amplitude, latency and duration
of ECochG potentials recorded in OPA8 patients are plotted
as a function of signal intensity in Figure 7, superimposed
on the corresponding mean values with 95% confidence limits
(shadowed areas) calculated for normally hearing controls. No
significant differences were found in CM amplitude (ANOVA;
F = 1.31, P = 0.252) in OPA8 patients compared to controls,
whereas SP was significantly reduced in amplitude (ANOVA;
F = 4.60, P = 0.041) and delayed in peak latency (ANOVA;
F = 4.48, P = 0.044). Compared to normally hearing controls,
the CAP recorded in OPA8 subjects was significantly decreased
in amplitude (ANOVA; F = 7.25, P = 0.012) and increased in
both peak latency (ANOVA; F = 19.17, P < 0.001) and duration
(ANOVA; F = 10.14, P < 0.05) (Figure 6). Overall, SP and
CAP potentials recorded in OPA8 patients with mild hearing loss
had higher thresholds, smaller amplitudes, delayed peak latencies
and increased durations in comparison with the group of OPA8
subjects with normal thresholds.
The effects of adaptation on the cochlear potentials were
studied by using a stimulation paradigm at high rates
(Eggermont and Odenthal, 1974; Santarelli and Arslan, 2013).
Figure 8A shows the ECochG waveforms obtained at seve-
ral intensities in a normally hearing control and in one
representative OPA8 patient in response to the sequence of click
stimuli reported at the bottom. In the normal control, CAP
amplitude showed a marked attenuation from the first (#1) to the
second (#2) click in the sequence (which corresponded to the first
click in the high-rate train), then a further drop was apparent
during the sustained train sequence. A similar behavior was
observed in the OPA8 patient, although SP and CAP amplitudes
were much smaller. In Figure 8B the means and standard errors
of ECochG response amplitudes calculated for both normally
hearing controls and OPA8 patients are reported as a function
of click position in the stimulus sequence at intensities from 120
to 90 dB p.e. SPL. Amplitudes were normalized to the first click
in the sequence. The amount of amplitude reduction obtained
in OPA8 patients at each stimulus level proved to be close to
that calculated for controls, consistent with a normal adaptation
pattern of auditory nerve fibers.
DISCUSSION
Our study demonstrates that the hearing dysfunction in OPA8
patients is underlain by hidden auditory neuropathy due to
degeneration of synaptic contacts between hair cells and auditory
nerve fibers. This results in abnormalities of the evoked auditory
nerve (SP, CAP) and ABRs potentials, which constitutes the
first sign of the disease, whereas hearing thresholds and speech
perception appear to be largely unaffected at an early stage. As
the disease progresses with age, hearing thresholds deteriorate,
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FIGURE 4 | Auditory brainstem responses (ABRs) from patients with
OPA8-related DOA. Brainstem potentials recorded at 90 dB nHL are shown
for individual OPA8 patients (s1–s10), one normally hearing control and two
subjects carrying missense mutations in the OPA1 gene (c1,c4). Compared to
the healthy control, ABRs were markedly attenuated in the OPA8 group with
normal hearing thresholds (PTA 10–15 dB), except for subject #4 who
showed normal brainstem potentials. Wave I was detected in all ears with
normal latency, whereas Waves III and V were prolonged in almost all ears.
ABR abnormalities were much more pronounced in the group of OPA8
patients with mild hearing loss, spanning from delay of individual ABR waves
to absent brainstem potentials, thus resembling the ABR waveforms recorded
from patients with OPA1-related DOA. PTA refers to the pure tone average
threshold level at 500, 1,000, 2,000, and 4,000 Hz; the potentials collected
from the right and left ear are indicated, respectively, by red and blue lines; the
vertical dashed lines refer to normal ABR waves peak latency. The asterisk is
to indicate that subject #9 had normal hearing threshold in the left ear.
speech perception difficulties arise and both CAP and ABRs
become further impaired.
We have previously characterized the hearing dysfunction
affecting patients with DOA due to missense mutations
in the OPA1 gene (Santarelli et al., 2015), who display
impaired speech perception, severe abnormalities of ABRs
and presence of OAEs consistent with auditory neuropathy.
Although the optic neuropathy found in the OPA8 family
seems indistinguishable from that described in the OPA1
disease (Carelli et al., 2011), the hearing dysfunction appears
profoundly different. First, in OPA8 patients the onset of
hearing symptoms is delayed compared to OPA1 subjects.
FIGURE 5 | Individual Wave I amplitudes from OPA8 patients showing normal
hearing thresholds and a group of normally hearing subjects (n = 14). Wave I
amplitude was significantly attenuated in OPA8 patients compared to
healthy controls.
Moreover, the hearing impairment mainly consists of difficulties
in understanding speech in the presence of noise, whereas in
OPA1 patients the speech perception is severely impaired also
in quiet environments. Most importantly, the combination of
audiological and electrophysiological findings points to different
pathophysiological mechanisms and sites of lesion.
Although complaining of subtle difficulties in understanding
speech such as great effort involved in listening in the
presence of noise, the youngest members of the OPA8 family
showed normal hearing thresholds and speech perception scores.
Interestingly, the only OPA8 patient with normal hearing
thresholds who showed a remarkably reduced performance
on speech perception tests, was 69 years old (Table 2), and
had normal hearing thresholds in one ear and mild hearing
loss in the other ear. Looking at the oldest patients, who
showed mild deafness bilaterally, the comparison of the mean
intelligibility scores with those obtained from a group of
subjects with cochlear deafness of the same age, revealed
lower performances, thus indicating that their difficulties in
speech understanding cannot be attributed solely to the hearing
threshold elevation or to presbycusis. Differences between OPA8
patients and controls appeared even more striking in speech
perception tests, particularly when administered in the presence
of competing noise.
Otoacoustic emissions and CM amplitudes were normal
in OPA8 patients, consistent with preservation of OHCs
function, whereas ABRs were abnormal in all but one subject.
Specifically, in the youngest patients with normal thresholds,
ABR morphology was preserved with detection of the main
ABR waves; however, the amplitude of ABR components was
markedly attenuated. Recent studies have reported that reduction
of Wave I amplitude constitutes the first sign of cochlear damage
in animals exposed to noise or in aging mice showing preserved
cochlear receptors (Liberman and Kujawa, 2017). This finding
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FIGURE 6 | Cochlear potentials recorded from patients with OPA8-related DOA. The ECochG responses to clicks at stimulus intensity from 120 to 60 dB p.e. SPL
recorded in four representative OPA8 patients, two with normal hearing thresholds (A) and two with mild hearing loss (B), are superimposed, respectively, on the
ECochG potentials recorded from two control subjects, one with normal hearing and the other affected by cochlear hearing loss. Compared to controls, cochlear
potentials recorded in OPA8 patients were attenuated in amplitude, delayed in peak latency and prolonged in duration, these changes being more pronounced in the
two OPA8 patients with mild hearing loss. In subject #2 (right ear), however, SP amplitude and latency were of control values. In the right panel (C), the ECochG
waveforms collected from two patients with AN associated with missense mutations in the OPA1 gene are shown for comparison. In this and in the subsequent
figures time “0” refers to CM onset.
has been attributed to diffuse loss of the IHCs synapses following
primary degeneration of unmyelinated neural terminals. An
attenuation of Wave I amplitude has also been found in
humans suffering from tinnitus associated with preservation
of hearing threshold (Schaette and McAlpine, 2011). The
group of OPA8 patients with normal hearing thresholds also
showed a significant reduction of Wave I amplitude compared
to healthy controls, consistent with degeneration of IHCs
synapses. Moreover, two subjects also showed prolongation of
the I–III interval latency. This might indicate a slowing of
signal conduction in the cochlear nerve possibly resulting from
damage to auditory nerve fibers. However, the prolongation of
the I–III interval latency could also result from the decrease
of the cochlear output related to synaptopathy (Don and
Kwong, 2002). ABR abnormalities were much more pronounced
in OPA8 patients with mild deafness, who showed profound
alterations of ABR morphology despite mild elevation of
hearing thresholds.
Acoustic reflexes to ipsilateral stimulation were detected in
all but one OPA8 patient. However, the reflex morphology
in response to 300 ms-tone stimuli was abnormal, in that
the first rapid deflection from baseline was almost completely
abolished with consequent delay of response peak latency,
which appeared significantly higher in comparison to healthy
controls. Recently, Valero et al. (2018) have shown that
acoustic reflexes are attenuated in mice affected by cochlear
synaptopathy induced by noise exposure. As proposed for
these noise-exposed mice, the slope reduction of acoustic
reflexes in OPA8 patients could result from a decrease of
rapid low-SR fiber activity, which is known to dominate the
afferent limb of the reflex (Kobler et al., 1992). Therefore,
together with the reduction of Wave I amplitude, the peak
delay of acoustic reflexes constitutes the first sign of AN
in OPA8 patients.
ECochG recordings revealed alterations of cochlear potentials
in all OPA8 subjects. Both SP and CAP showed a striking
reduction in amplitude, consistent with a reduction of cochlear
output. This finding accords with the suprathreshold attenuation
of ABR Wave I amplitude; however, it constitutes a much more
reliable index of cochlear output reduction. A decrease of SP and
CAP amplitude is also apparent in cochlear deafness (Santarelli
and Arslan, 2013; Santarelli et al., 2016) because of reduced
cochlear sensitivity related to loss of the cochlear amplifier.
However, differently from patients with cochlear lesions, OPA8
subjects also showed an increase of both CAP peak latency and
duration, consistent with a selective reduction of rapid low-
SR fibers activity. The attenuation in amplitude of ECochG
potentials and the delay of SP and CAP peak latency were more
pronounced in the group of patients with mild hearing loss,
who were the oldest members of OPA8 family. These patients
also showed a remarkable increase of CAP thresholds despite
mild hearing threshold elevation. These findings corroborate the
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FIGURE 7 | Amplitude, latency and duration of ECochG potentials recorded from OPA8 patients. Individual (colored squares) and mean values (dashed line) of
amplitude, latency and duration of ECochG potentials obtained in OPA8 patients are plotted as a function of signal intensity superimposed on the corresponding
mean values (continuous line, black open squares) with 95% confidence limits (shadowed areas) calculated for normally hearing controls. Compared to controls, the
SP and CAP recorded in OPA8 subjects were decreased in amplitude and increased in peak latency and duration, whereas no differences were found in CM
amplitudes. Differences between OPA8 patients and controls were more pronounced for subjects with mild deafness (blue squares) compared to those with normal
hearing thresholds (red squares).
hypothesis that in the youngest members of the OPA8 family
synaptic damage was far less advanced.
Taken together, speech perception measures and ABR and
ECochG findings, may indicate that the youngest members of
the OPA8 family show subtle hearing dysfunctions associated
with reduction in amplitude and increase in latency of auditory
evoked potentials. As the disease progresses over time, auditory
perceptions worsen, ABRs are absent or show profound
alterations, while CAP shows further attenuation in amplitude
and increase in peak latency. Thus, alterations of ABR and
ECochG potentials seem to mirror the progressive deterioration
of speech perception abilities. Similar changes have been reported
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FIGURE 8 | Adaptation of ECochG potentials in OPA8-related DOA. ECochG waveforms recorded at stimulation intensities from 120 to 90 dB p.e. SPL in one
normally hearing control and in one OPA8 patient (s2) in response to the stimulus sequence reported at the bottom are displayed in the left panel (A). On the right
(B), the mean and standard errors of normalized CAP amplitudes are reported as a function of click position in the stimulus sequence for both controls and OPA8
patients. The size of attenuation of cochlear potentials during adaptation calculated for OPA8 subjects was within the range of the CAP attenuation calculated for
controls. The horizontal and vertical dashed lines indicate baseline and CAP peak, respectively.
by Rance et al. (2012) in two patients with Friedreich ataxia.
One of these subjects showed ABR alterations worsening with
time, which were mirrored by progressively decreasing spatial
listening abilities. In contrast, no changes in ABR potentials were
observed during longitudinal assessment in the second patient
who retained binaural processing abilities.
ECochG recordings obtained from OPA8 patients showed
profound differences in comparison to subjects harboring OPA1
mutations, who showed the typical profile of classical post-
synaptic AN. In the latter, the synchronous CAP was replaced by a
prolonged low-amplitude negative potential, which is believed to
result from activation of damaged neural fibers (Santarelli et al.,
2015). In contrast, in OPA8 patients the morphology of the SP-
CAP complex was preserved, thus indicating preservation of the
dynamics of activation of auditory nerve fibers. This hypothesis is
corroborated by the time course of adaptation of CAP potentials
during stimulation at high frequency. The amplitude of CAP
responses, in fact, decreased during adaptation, and the amount
of attenuation closely followed that calculated for normally
hearing controls. Wynne et al. (2013) have measured the changes
of Wave V amplitude evoked by rapid trains of clicks in patients
affected by AN. They found that Wave V was recorded in
healthy controls in response to every click of the train sequence,
whereas in patients with hereditary neuropathy due to auditory
fiber degeneration, Wave V was recorded only in response to
the initial click of the stimulus sequence consistent with a
neural conduction block. In OPA8 patients, the identification
of a well-synchronized CAP in response to every click of the
train sequence and the time course of adaptation rule out the
hypothesis of a conduction block possibly related to auditory
nerve fiber degeneration.
Overall, ECochG recordings from OPA8 family are consistent
with the findings obtained by Salvi et al. (2017) in chinchillas
after administration of the ototoxic agent carboplatin. Moderate
doses of this toxic agent resulted in degeneration of the
afferent terminals at the base of IHCs followed by diffuse
IHCs loss. Following carboplatin administration an attenuation
of both SP and CAP potentials was observed in ECochG
recordings, the amount of amplitude reduction being related
to the amount of IHCs loss as evaluated histologically. It is
noteworthy that the hearing thresholds measured in chinchillas
after carboplatin administration were preserved in the presence
of small IHCs lesions (<35% of IHCs loss) and were only
slightly increased after moderate IHCs loss (40–75%). Thus,
we speculate that both the audiological and electrophysiological
alterations observed in the two groups of OPA8 patients, young
adults and elderly individuals, reflect different amounts of IHCs
synaptic degeneration.
Although behavioral hearing thresholds measured in quiet
environments in chinchillas were not affected until IHC loss
exceeded about 40%, hearing thresholds obtained in the presence
of noise were significantly elevated compared to controls in
animals with small IHCs lesions. This was explained by admitting
that the central auditory system is able to compensate for a
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FIGURE 9 | Audiometric and electrophysiological findings from one patient (subj. #10) with OPA8-related DOA. Hearing thresholds and articulation gain curves
indicate bilateral mild hearing loss and slight reduction of speech intelligibility in the right ear. OAEs and auditory evoked potentials (ABRs, ECochG and slow vertex
potentials, SVR) recordings are reported only for the right ear. DPOAEs were detected with normal amplitude, whereas ABRs were absent. ECochG recordings
showed only the CM potential, whereas no SP or CAP responses were detected despite the relative preservation of hearing thresholds. Slow vertex cortical (SVR)
potentials were recorded despite the absence of synchronized auditory nerve response.
small decrease in the cochlear output so that cochlear damage
becomes apparent only in challenging conditions. Indeed, Salvi
et al. (2017) found that the evoked potentials recorded from the
auditory cortex of chinchillas in response to tone-burst stimuli
were remarkably enhanced after carboplatin administration.
Based on this finding, they hypothesized that the relative
preservation of hearing thresholds after administration of low-
to-moderate doses of carboplatin results from compensatory
mechanisms set in action by the central auditory system, which
increases its gain in the attempt to counteract the reduction of
cochlear output. The effectiveness of these compensatory effects
is likely to be reduced in more challenging conditions such as
hearing in the presence of noise, particularly when the percentage
of IHCs loss exceeds 50%.
Similar mechanisms might come into play in OPA8 patients.
In younger subjects the preservation of both hearing thresholds
and speech perception may be achieved by central compensatory
mechanisms counteracting the attenuation of the cochlear
output, whereas in older subjects both the deterioration of
hearing thresholds and the impairment of speech perception
could possibly reflect a decreased effectiveness of central
compensating mechanisms in counteracting a further decrease
of cochlear output. This hypothesis is also supported by the
findings reported by Chambers et al. (2016), who observed
increased gains in firing rate of auditory cortex neurons in mice
after lesioning cochlear nerve synapses through round window
application of ouabain. After ouabain administration auditory
nerve activity was severely depressed, whereas tone-evoked
responses in auditory cortex progressively recovered to firing
levels which were even greater than control values. In contrast,
spike timing precision and decoding accuracy for pulse trains and
speech tokens remained impaired.
Interestingly, the data obtained in this animal model
resembled the findings we collected from subject #10, who
showed mild hearing loss associated with a slight reduction in
speech intelligibility (Figure 9) together with decreased speech
perception in the presence of noise. In this subject, OAEs
were detected bilaterally, whereas ABRs were absent. ECochG
recordings showed only the CM potential, whereas no SP or
CAP responses were detected despite the relative preservation
of hearing thresholds. In contrast, Slow Vertex Potentials (SVR)
were clearly recorded in response to click stimuli. Long-latency
responses with small amplitude and delayed latency have been
obtained in other patients with AN (Starr et al., 1996). This
finding was attributed to the relatively longer duration of cortical
evoked responses compared to brainstem potentials, the latter
requiring a highly synchronous cochlear nerve activity for their
generation. Nevertheless, the findings of relatively preserved
speech perception in quiet environments together with robust
SVR recordings, which were comparable in both amplitude and
peak latency to those evoked in normally hearing individuals
(Martin et al., 2007), corroborate the hypothesis that an increase
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in gain of the central auditory system compensates for the
cochlear output reduction in OPA8 subject #10.
CONCLUSION
We document that the hearing dysfunction affecting OPA8
patients is underlain by hidden AN, possibly resulting from
terminal afferent degeneration followed by IHCs loss. The
functional alterations consist of abnormalities of both ABR
and ECochG potentials together with poor morphology
of middle ear acoustic reflexes at an early stage of the
disease, whereas mild hearing loss and impairment of speech
perception become apparent only at an advanced stage.
Central mechanisms are likely to counteract the decrease of
peripheral input and guarantee full compensation at an early
stage of the disease.
These findings provide a distinctive phenotypic profile of
DOA associated with the OPA8 locus as compared with the
OPA1-related DOA, which was associated to the classical profile
of post-synaptic AN. Elucidation of the molecular pathogenesis
will certainly shed further light on the selective auditory terminals
and IHCs damage in patients with OPA8-related DOA.
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